Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunic (IMUX)
NASDAQ:IMUX
Immunic (IMUX) Stock Price & Analysis
972 Followers
IMUX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.95 - $3.17
Previous Close$1.2
Volume313.01K
Average Volume (3M)801.02K
Market Cap
$54.85M
Enterprise Value-$4.74M
Total Cash (Recent Filing)$59.70M
Total Debt (Recent Filing)$789.00K
Price to Earnings (P/E)-0.4
Beta1.04
Next Earnings
Feb 22, 2024EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.26
Shares Outstanding45,145,383
10 Day Avg. Volume266,957
30 Day Avg. Volume801,019
Standard Deviation0.25
R-Squared0.17
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.12
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.04
Forecast
1Y Price Target
$13.33Price Target Upside997.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Immunic News
Pre-EarningsImmunic, Inc. (IMUX) Q3 Earnings Cheat Sheet
Ownership Overview
1.03% Insiders
5.11% Mutual Funds
31.10% Other Institutional Investors
62.75% Public Companies and Individual Investors
IMUX FAQ
What was Immunic’s price range in the past 12 months?
Immunic lowest stock price was $0.94 and its highest was $3.17 in the past 12 months.
What is Immunic’s market cap?
Currently, no data Available
When is Immunic’s upcoming earnings report date?
Immunic’s upcoming earnings report date is Feb 22, 2024 which is in 80 days.
How were Immunic’s earnings last quarter?
Immunic released its earnings results on Nov 14, 2023. The company reported -$0.51 earnings per share for the quarter, beating the consensus estimate of -$0.548 by $0.038.
Is Immunic overvalued?
According to Wall Street analysts Immunic’s price is currently Undervalued.
Does Immunic pay dividends?
Immunic does not currently pay dividends.
What is Immunic’s EPS estimate?
Immunic’s EPS estimate is -$0.5.
How many shares outstanding does Immunic have?
Immunic has 45,145,382 shares outstanding.
What happened to Immunic’s price movement after its last earnings report?
Immunic reported an EPS of -$0.51 in its last earnings report, beating expectations of -$0.548. Following the earnings report the stock price went up 2.062%.
Which hedge fund is a major shareholder of Immunic?
Among the largest hedge funds holding Immunic’s share is Omega Fund Management, LLC. It holds Immunic’s shares valued at 3M.
---
Immunic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.33 (997.12% Upside)
$13.33 (997.12% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.11%
12-Months-Change
Fundamentals
Return on Equity
-163.49%
Trailing 12-Months
Asset Growth
-44.69%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Immunic
Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
---
Top 5 ETFs holding IMUX
Vanguard Total Stock Market ETF
$1.21M
Up to five ETFs with an Outperform Smart Score that hold IMUX. The ETFs are listed according to market value of IMUX within the ETF
Sarepta Therapeutics
―
Ultragenyx Pharmaceutical
―
MacroGenics
―
Vertex Pharmaceuticals
―
---